Skip to main content
. Author manuscript; available in PMC: 2010 Apr 1.
Published in final edited form as: Expert Opin Drug Metab Toxicol. 2009 Apr;5(4):353–366. doi: 10.1517/17425250902877698

Table 1.

SNPs in human NAT1 coding region

SNPa rs identifierb SNP500 Cancer IDc Amino acid change NAT1 allele/haplotype Functional effectd
21T>G 4986992 NAT1-18 L7L NAT1*27 Synonymous
97C>T 56318881 NAT1-11 R33X NAT1*19 Decrease
190C>T 56379106 NAT1-19 R64W NAT1*17 Decrease
363C>T 8190858 NAT1-26 V121V Synonymous
402T>C P134P NAT1*20 Synonymous
445G>A 4987076 NAT1-05 V149I NAT1*11
459G>A 4986990 NAT1-06 T153T NAT1*11 Synonymous
559C>T 5030839 NAT1-10 R187X NAT1*15 Decrease
560G>A 4986782 NAT1-07 R187Q NAT1*14 Decrease
613A>G M205V NAT1*21 None
640T>G 4986783 S214A NAT1*11
752A>T D251V NAT1*22 Decrease
777T>C 4986991 NAT1-15 S259S NAT1*23 Synonymous
781G>A E261K NAT1*24 None
787A>G I263V NAT1*25 None
a

Reference gene sequence published in Genbank Assession Number X17059. Adapted from http://N-acetyltransferasenomenclature.louisville.edu

b

Not all SNPs have been designated.

c

Accessed from http://snp500cancer.nci.nih.gov/snplist.cfm?gene_id=NAT1&mode=valid. This SNP nomenclature is distinct from the NAT1 allele (haplotype) nomenclature.

d

SNPs are non-synonymous unless otherwise indicated. Only functional effects supported with experimental data are provided.